{
    "markdown": "<a id='32d6eea3-f5ee-4a8a-99fd-e485a6d5f28c'></a>\n\nPfizer Pharmaceuticals Group\n\n<a id='1f2f1a70-fff5-459b-8cc0-c46fd71f9687'></a>\n\nAPPENDIX B: Diagnostic Worksheet for Diabetic Peripheral Neuropathy:\n\n<a id='0b3e0ee8-0be9-4c29-8fe4-ea37e4f93774'></a>\n\nA. NEUROLOGICAL HISTORY\nYour standard neurological history should be performed. This history should include an inquiry into possible exposure to neurotoxic drugs or chemicals, and a family history of neurologic disease, weakness, or arthritis and joint deformities. Also make specific and detailed inquiry about symptoms of sensory, motor, and autonomic dysfunction.\n\n1. Based on your history, does the patient have:\n\noption No: [ ] option Yes: [ ]\na) A condition other than diabetes which could cause neuropathy?\noption No: [ ] option Yes: [ ]\nb) Exposure to known neurotoxins?\noption No: [ ] option Yes: [ ]\nc) A family history of neuromuscular disorders?\n\nIf Yes to any of the above, reconsider the diagnosis of diabetic peripheral neuropathy. Patient is not allowed to enter study if there is doubt about the diagnosis or a concomitant condition is present which could confuse the assessment of pain due to diabetic peripheral neuropathy.\n\n<a id='bdad91d0-cf23-4d02-9f21-3c2489fd5c7e'></a>\n\n2. Are any of the following sensory symptoms present in the hands or feet?\n\na) Numbness\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nb) Dysesthesias, paresthesias\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nc) Allodynia\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nd) Burning/aching stabbing pain\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\n\nNote: If symptoms present in hands only, consider alternative diagnosis!\n\n3. Are any of the following motor symptoms present?\n\na) Ankle weakness\noption No: [ ]\noption Yes: [ ]\nb) Cramps\noption No: [ ]\noption Yes: [ ]\n\n4. Are any of the following autonomic symptoms present?\n\nPostural Hypotension\na) Weakness on standing relieved by lying down\noption No: [ ]\noption Yes: [ ]\nb) Fainting on standing relieved by lying down\noption No: [ ]\noption Yes: [ ]\n\nGastroparesis\nc) Dysphagia (difficulty in swallowing)\noption No: [ ]\noption Yes: [ ]\nd) Anorexia\noption No: [ ]\noption Yes: [ ]\ne) Nausea\noption No: [ ]\noption Yes: [ ]\nf) Vomiting\noption No: [ ]\noption Yes: [ ]\ng) Vague fullness after meal\noption No: [ ]\noption Yes: [ ]\n\nDiabetic Diarrhea\nh) Nocturnal diarrhea\noption No: [ ]\noption Yes: [ ]\ni) Fecal incontinence\noption No: [ ]\noption Yes: [ ]\nj) More than 20 bowel movements/day\noption No: [ ]\noption Yes: [ ]\n\nColonic Atony\nk) Less than 2 bowel movements/week\noption No: [ ]\noption Yes: [ ]\nl) Less than 1 bowel movement/3 days\noption No: [ ]\noption Yes: [ ]\n\n<a id='3c945442-af61-4bb1-94e7-3f28461e1e2b'></a>\n\n---\nProtocol ID A945-1008\n\n<a id='54b3bc93-451b-4c63-b7f4-f77c6cdff923'></a>\n\n40\n\n<a id='3687089c-30f6-4fb9-a6f4-baac0e82fd4d'></a>\n\nWorking Protocol inc. Amendment #2: August 7, 2002\n\n<a id='5f43a550-00b3-4384-921f-4d253fd1ac26'></a>\n\nCONFIDENTIAL\n\n<a id='d6f7aec4-fd2a-4a62-8e49-caea96d3740b'></a>\n\nPfizer_MPatel_0203749\n\n<a id='17b430b6-bef6-4c6f-94ef-a3610a829684'></a>\n\nSource: https://www.industrydocuments.ucsf.edu/docs/lpjm0223",
    "chunks": [
        {
            "markdown": "<a id='32d6eea3-f5ee-4a8a-99fd-e485a6d5f28c'></a>\n\nPfizer Pharmaceuticals Group",
            "type": "marginalia",
            "id": "32d6eea3-f5ee-4a8a-99fd-e485a6d5f28c",
            "grounding": {
                "box": {
                    "left": 0.07224342226982117,
                    "top": 0.048271544277668,
                    "right": 0.24754518270492554,
                    "bottom": 0.06514102965593338
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='1f2f1a70-fff5-459b-8cc0-c46fd71f9687'></a>\n\nAPPENDIX B: Diagnostic Worksheet for Diabetic Peripheral Neuropathy:",
            "type": "text",
            "id": "1f2f1a70-fff5-459b-8cc0-c46fd71f9687",
            "grounding": {
                "box": {
                    "left": 0.07144364714622498,
                    "top": 0.09281950443983078,
                    "right": 0.7035341262817383,
                    "bottom": 0.11548987776041031
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='0b3e0ee8-0be9-4c29-8fe4-ea37e4f93774'></a>\n\nA. NEUROLOGICAL HISTORY\nYour standard neurological history should be performed. This history should include an inquiry into possible exposure to neurotoxic drugs or chemicals, and a family history of neurologic disease, weakness, or arthritis and joint deformities. Also make specific and detailed inquiry about symptoms of sensory, motor, and autonomic dysfunction.\n\n1. Based on your history, does the patient have:\n\noption No: [ ] option Yes: [ ]\na) A condition other than diabetes which could cause neuropathy?\noption No: [ ] option Yes: [ ]\nb) Exposure to known neurotoxins?\noption No: [ ] option Yes: [ ]\nc) A family history of neuromuscular disorders?\n\nIf Yes to any of the above, reconsider the diagnosis of diabetic peripheral neuropathy. Patient is not allowed to enter study if there is doubt about the diagnosis or a concomitant condition is present which could confuse the assessment of pain due to diabetic peripheral neuropathy.",
            "type": "text",
            "id": "0b3e0ee8-0be9-4c29-8fe4-ea37e4f93774",
            "grounding": {
                "box": {
                    "left": 0.0694475769996643,
                    "top": 0.1234724149107933,
                    "right": 0.8974081873893738,
                    "bottom": 0.33386164903640747
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='bdad91d0-cf23-4d02-9f21-3c2489fd5c7e'></a>\n\n2. Are any of the following sensory symptoms present in the hands or feet?\n\na) Numbness\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nb) Dysesthesias, paresthesias\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nc) Allodynia\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nd) Burning/aching stabbing pain\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\n\nNote: If symptoms present in hands only, consider alternative diagnosis!\n\n3. Are any of the following motor symptoms present?\n\na) Ankle weakness\noption No: [ ]\noption Yes: [ ]\nb) Cramps\noption No: [ ]\noption Yes: [ ]\n\n4. Are any of the following autonomic symptoms present?\n\nPostural Hypotension\na) Weakness on standing relieved by lying down\noption No: [ ]\noption Yes: [ ]\nb) Fainting on standing relieved by lying down\noption No: [ ]\noption Yes: [ ]\n\nGastroparesis\nc) Dysphagia (difficulty in swallowing)\noption No: [ ]\noption Yes: [ ]\nd) Anorexia\noption No: [ ]\noption Yes: [ ]\ne) Nausea\noption No: [ ]\noption Yes: [ ]\nf) Vomiting\noption No: [ ]\noption Yes: [ ]\ng) Vague fullness after meal\noption No: [ ]\noption Yes: [ ]\n\nDiabetic Diarrhea\nh) Nocturnal diarrhea\noption No: [ ]\noption Yes: [ ]\ni) Fecal incontinence\noption No: [ ]\noption Yes: [ ]\nj) More than 20 bowel movements/day\noption No: [ ]\noption Yes: [ ]\n\nColonic Atony\nk) Less than 2 bowel movements/week\noption No: [ ]\noption Yes: [ ]\nl) Less than 1 bowel movement/3 days\noption No: [ ]\noption Yes: [ ]",
            "type": "text",
            "id": "bdad91d0-cf23-4d02-9f21-3c2489fd5c7e",
            "grounding": {
                "box": {
                    "left": 0.06565093994140625,
                    "top": 0.33533957600593567,
                    "right": 0.7468309998512268,
                    "bottom": 0.8810973167419434
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='3c945442-af61-4bb1-94e7-3f28461e1e2b'></a>\n\n---\nProtocol ID A945-1008",
            "type": "text",
            "id": "3c945442-af61-4bb1-94e7-3f28461e1e2b",
            "grounding": {
                "box": {
                    "left": 0.06333351135253906,
                    "top": 0.8887297511100769,
                    "right": 0.20376843214035034,
                    "bottom": 0.9057210087776184
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='54b3bc93-451b-4c63-b7f4-f77c6cdff923'></a>\n\n40",
            "type": "marginalia",
            "id": "54b3bc93-451b-4c63-b7f4-f77c6cdff923",
            "grounding": {
                "box": {
                    "left": 0.3798578083515167,
                    "top": 0.8901237845420837,
                    "right": 0.4114965498447418,
                    "bottom": 0.9042882323265076
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='3687089c-30f6-4fb9-a6f4-baac0e82fd4d'></a>\n\nWorking Protocol inc. Amendment #2: August 7, 2002",
            "type": "text",
            "id": "3687089c-30f6-4fb9-a6f4-baac0e82fd4d",
            "grounding": {
                "box": {
                    "left": 0.5545668601989746,
                    "top": 0.8896658420562744,
                    "right": 0.8677612543106079,
                    "bottom": 0.9067119359970093
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='5f43a550-00b3-4384-921f-4d253fd1ac26'></a>\n\nCONFIDENTIAL",
            "type": "marginalia",
            "id": "5f43a550-00b3-4384-921f-4d253fd1ac26",
            "grounding": {
                "box": {
                    "left": 0.015602171421051025,
                    "top": 0.9524139165878296,
                    "right": 0.14138343930244446,
                    "bottom": 0.9703693389892578
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='d6f7aec4-fd2a-4a62-8e49-caea96d3740b'></a>\n\nPfizer_MPatel_0203749",
            "type": "text",
            "id": "d6f7aec4-fd2a-4a62-8e49-caea96d3740b",
            "grounding": {
                "box": {
                    "left": 0.7866883873939514,
                    "top": 0.9538939595222473,
                    "right": 0.947651207447052,
                    "bottom": 0.9719821810722351
                },
                "page": 0
            }
        },
        {
            "markdown": "<a id='17b430b6-bef6-4c6f-94ef-a3610a829684'></a>\n\nSource: https://www.industrydocuments.ucsf.edu/docs/lpjm0223",
            "type": "marginalia",
            "id": "17b430b6-bef6-4c6f-94ef-a3610a829684",
            "grounding": {
                "box": {
                    "left": 0.22237104177474976,
                    "top": 0.9781211018562317,
                    "right": 0.7798414826393127,
                    "bottom": 0.9981732964515686
                },
                "page": 0
            }
        }
    ],
    "splits": [
        {
            "class": "full",
            "identifier": "full",
            "pages": [
                0
            ],
            "markdown": "<a id='32d6eea3-f5ee-4a8a-99fd-e485a6d5f28c'></a>\n\nPfizer Pharmaceuticals Group\n\n<a id='1f2f1a70-fff5-459b-8cc0-c46fd71f9687'></a>\n\nAPPENDIX B: Diagnostic Worksheet for Diabetic Peripheral Neuropathy:\n\n<a id='0b3e0ee8-0be9-4c29-8fe4-ea37e4f93774'></a>\n\nA. NEUROLOGICAL HISTORY\nYour standard neurological history should be performed. This history should include an inquiry into possible exposure to neurotoxic drugs or chemicals, and a family history of neurologic disease, weakness, or arthritis and joint deformities. Also make specific and detailed inquiry about symptoms of sensory, motor, and autonomic dysfunction.\n\n1. Based on your history, does the patient have:\n\noption No: [ ] option Yes: [ ]\na) A condition other than diabetes which could cause neuropathy?\noption No: [ ] option Yes: [ ]\nb) Exposure to known neurotoxins?\noption No: [ ] option Yes: [ ]\nc) A family history of neuromuscular disorders?\n\nIf Yes to any of the above, reconsider the diagnosis of diabetic peripheral neuropathy. Patient is not allowed to enter study if there is doubt about the diagnosis or a concomitant condition is present which could confuse the assessment of pain due to diabetic peripheral neuropathy.\n\n<a id='bdad91d0-cf23-4d02-9f21-3c2489fd5c7e'></a>\n\n2. Are any of the following sensory symptoms present in the hands or feet?\n\na) Numbness\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nb) Dysesthesias, paresthesias\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nc) Allodynia\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\nd) Burning/aching stabbing pain\noption No: [ ]\noption Both Hands and Feet: [ ]\noption Feet Only: [ ]\noption Hands Only: [ ]\n\nNote: If symptoms present in hands only, consider alternative diagnosis!\n\n3. Are any of the following motor symptoms present?\n\na) Ankle weakness\noption No: [ ]\noption Yes: [ ]\nb) Cramps\noption No: [ ]\noption Yes: [ ]\n\n4. Are any of the following autonomic symptoms present?\n\nPostural Hypotension\na) Weakness on standing relieved by lying down\noption No: [ ]\noption Yes: [ ]\nb) Fainting on standing relieved by lying down\noption No: [ ]\noption Yes: [ ]\n\nGastroparesis\nc) Dysphagia (difficulty in swallowing)\noption No: [ ]\noption Yes: [ ]\nd) Anorexia\noption No: [ ]\noption Yes: [ ]\ne) Nausea\noption No: [ ]\noption Yes: [ ]\nf) Vomiting\noption No: [ ]\noption Yes: [ ]\ng) Vague fullness after meal\noption No: [ ]\noption Yes: [ ]\n\nDiabetic Diarrhea\nh) Nocturnal diarrhea\noption No: [ ]\noption Yes: [ ]\ni) Fecal incontinence\noption No: [ ]\noption Yes: [ ]\nj) More than 20 bowel movements/day\noption No: [ ]\noption Yes: [ ]\n\nColonic Atony\nk) Less than 2 bowel movements/week\noption No: [ ]\noption Yes: [ ]\nl) Less than 1 bowel movement/3 days\noption No: [ ]\noption Yes: [ ]\n\n<a id='3c945442-af61-4bb1-94e7-3f28461e1e2b'></a>\n\n---\nProtocol ID A945-1008\n\n<a id='54b3bc93-451b-4c63-b7f4-f77c6cdff923'></a>\n\n40\n\n<a id='3687089c-30f6-4fb9-a6f4-baac0e82fd4d'></a>\n\nWorking Protocol inc. Amendment #2: August 7, 2002\n\n<a id='5f43a550-00b3-4384-921f-4d253fd1ac26'></a>\n\nCONFIDENTIAL\n\n<a id='d6f7aec4-fd2a-4a62-8e49-caea96d3740b'></a>\n\nPfizer_MPatel_0203749\n\n<a id='17b430b6-bef6-4c6f-94ef-a3610a829684'></a>\n\nSource: https://www.industrydocuments.ucsf.edu/docs/lpjm0223",
            "chunks": [
                "32d6eea3-f5ee-4a8a-99fd-e485a6d5f28c",
                "1f2f1a70-fff5-459b-8cc0-c46fd71f9687",
                "0b3e0ee8-0be9-4c29-8fe4-ea37e4f93774",
                "bdad91d0-cf23-4d02-9f21-3c2489fd5c7e",
                "3c945442-af61-4bb1-94e7-3f28461e1e2b",
                "54b3bc93-451b-4c63-b7f4-f77c6cdff923",
                "3687089c-30f6-4fb9-a6f4-baac0e82fd4d",
                "5f43a550-00b3-4384-921f-4d253fd1ac26",
                "d6f7aec4-fd2a-4a62-8e49-caea96d3740b",
                "17b430b6-bef6-4c6f-94ef-a3610a829684"
            ]
        }
    ],
    "grounding": {
        "32d6eea3-f5ee-4a8a-99fd-e485a6d5f28c": {
            "box": {
                "left": 0.07224342226982117,
                "top": 0.048271544277668,
                "right": 0.24754518270492554,
                "bottom": 0.06514102965593338
            },
            "page": 0,
            "type": "chunkMarginalia"
        },
        "1f2f1a70-fff5-459b-8cc0-c46fd71f9687": {
            "box": {
                "left": 0.07144364714622498,
                "top": 0.09281950443983078,
                "right": 0.7035341262817383,
                "bottom": 0.11548987776041031
            },
            "page": 0,
            "type": "chunkText"
        },
        "0b3e0ee8-0be9-4c29-8fe4-ea37e4f93774": {
            "box": {
                "left": 0.0694475769996643,
                "top": 0.1234724149107933,
                "right": 0.8974081873893738,
                "bottom": 0.33386164903640747
            },
            "page": 0,
            "type": "chunkText"
        },
        "bdad91d0-cf23-4d02-9f21-3c2489fd5c7e": {
            "box": {
                "left": 0.06565093994140625,
                "top": 0.33533957600593567,
                "right": 0.7468309998512268,
                "bottom": 0.8810973167419434
            },
            "page": 0,
            "type": "chunkText"
        },
        "3c945442-af61-4bb1-94e7-3f28461e1e2b": {
            "box": {
                "left": 0.06333351135253906,
                "top": 0.8887297511100769,
                "right": 0.20376843214035034,
                "bottom": 0.9057210087776184
            },
            "page": 0,
            "type": "chunkText"
        },
        "54b3bc93-451b-4c63-b7f4-f77c6cdff923": {
            "box": {
                "left": 0.3798578083515167,
                "top": 0.8901237845420837,
                "right": 0.4114965498447418,
                "bottom": 0.9042882323265076
            },
            "page": 0,
            "type": "chunkMarginalia"
        },
        "3687089c-30f6-4fb9-a6f4-baac0e82fd4d": {
            "box": {
                "left": 0.5545668601989746,
                "top": 0.8896658420562744,
                "right": 0.8677612543106079,
                "bottom": 0.9067119359970093
            },
            "page": 0,
            "type": "chunkText"
        },
        "5f43a550-00b3-4384-921f-4d253fd1ac26": {
            "box": {
                "left": 0.015602171421051025,
                "top": 0.9524139165878296,
                "right": 0.14138343930244446,
                "bottom": 0.9703693389892578
            },
            "page": 0,
            "type": "chunkMarginalia"
        },
        "d6f7aec4-fd2a-4a62-8e49-caea96d3740b": {
            "box": {
                "left": 0.7866883873939514,
                "top": 0.9538939595222473,
                "right": 0.947651207447052,
                "bottom": 0.9719821810722351
            },
            "page": 0,
            "type": "chunkText"
        },
        "17b430b6-bef6-4c6f-94ef-a3610a829684": {
            "box": {
                "left": 0.22237104177474976,
                "top": 0.9781211018562317,
                "right": 0.7798414826393127,
                "bottom": 0.9981732964515686
            },
            "page": 0,
            "type": "chunkMarginalia"
        }
    },
    "metadata": {
        "filename": "lpjm0223_58.png",
        "org_id": null,
        "page_count": 1,
        "duration_ms": 8402,
        "credit_usage": 3.0,
        "job_id": "p46vuwuhqodcoi7ms8x3lf5p4",
        "version": "dpt-2-20250919"
    }
}